These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17420067)

  • 1. Prognostic value of KIT expression in small cell lung cancer.
    López-Martin A; Ballestín C; Garcia-Carbonero R; Castaño A; Lopez-Ríos F; López-Encuentra A; Sánchez-Cespedes M; Castellano D; Bartolomé A; Cortés-Funes H; Paz-Ares L
    Lung Cancer; 2007 Jun; 56(3):405-13. PubMed ID: 17420067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications.
    Micke P; Basrai M; Faldum A; Bittinger F; Rönnstrand L; Blaukat A; Beeh KM; Oesch F; Fischer B; Buhl R; Hengstler JG
    Clin Cancer Res; 2003 Jan; 9(1):188-94. PubMed ID: 12538468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of c-kit expression in small cell lung cancer: prevalence and prognostic implications.
    Camps C; Sirera R; Bremnes RM; Garde J; Safont MJ; Blasco A; Berrocal A; Sánchez JJ; Calabuig C; Martorell M
    Lung Cancer; 2006 Jun; 52(3):343-7. PubMed ID: 16574270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of fragile histidine triad and c-kit is relevant for prediction of survival in patients with small cell lung cancer.
    Rehfeld N; Geddert H; Atamna A; Gabbert HE; Steidl U; Fenk R; Kronenwett R; Haas R; Rohr UP
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2232-8. PubMed ID: 17119051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological significance of expression of c-kit protein in neuroendocrine lung carcinoma].
    Zhao P; Hou N; Shao Y; Li XH
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1526-9. PubMed ID: 16179109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance.
    Boldrini L; Ursino S; Gisfredi S; Faviana P; Donati V; Camacci T; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4101-8. PubMed ID: 15217946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
    Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
    Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?
    Raspollini MR; Susini T; Amunni G; Paglierani M; Taddei A; Marchionni M; Scarselli G; Taddei GL
    Gynecol Oncol; 2005 Jan; 96(1):159-67. PubMed ID: 15589595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of c-kit protein expression in small-cell lung carcinoma and its implication for prognosis.
    Naeem M; Dahiya M; Clark JI; Creech SD; Alkan S
    Hum Pathol; 2002 Dec; 33(12):1182-7. PubMed ID: 12514786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer.
    Rohr UP; Rehfeld N; Geddert H; Pflugfelder L; Bruns I; Neukirch J; Rohrbeck A; Grote HJ; Steidl U; Fenk R; Opalka B; Gabbert HE; Kronenwett R; Haas R
    Clin Cancer Res; 2005 Jan; 11(1):180-5. PubMed ID: 15671544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of imatinib in patients with small cell lung cancer.
    Johnson BE; Fischer T; Fischer B; Dunlop D; Rischin D; Silberman S; Kowalski MO; Sayles D; Dimitrijevic S; Fletcher C; Hornick J; Salgia R; Le Chevalier T
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5880-7. PubMed ID: 14676110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kit expression in small cell carcinomas of the lung: effects of chemotherapy.
    Rossi G; Cavazza A; Marchioni A; Migaldi M; Bavieri M; Facciolongo N; Petruzzelli S; Longo L; Tamberi S; Crinò L
    Mod Pathol; 2003 Oct; 16(10):1041-7. PubMed ID: 14559988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome.
    Joseph MG; Banerjee D; Kocha W; Feld R; Stitt LW; Cherian MG
    Cancer; 2001 Aug; 92(4):836-42. PubMed ID: 11550155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and prognostic significance of kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancer.
    Blackhall FH; Pintilie M; Michael M; Leighl N; Feld R; Tsao MS; Shepherd FA
    Clin Cancer Res; 2003 Jun; 9(6):2241-7. PubMed ID: 12796392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin expression and prognostic significance in non-small cell lung cancer.
    Donati V; Boldrini L; Dell'Omodarme M; Prati MC; Faviana P; Camacci T; Lucchi M; Mussi A; Santoro M; Basolo F; Fontanini G
    Clin Cancer Res; 2005 Sep; 11(18):6459-65. PubMed ID: 16166420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.
    Geller MA; Argenta P; Bradley W; Dusenbery KE; Brooker D; Downs LS; Judson PL; Carson LF; Boente MP
    Gynecol Oncol; 2004 Dec; 95(3):632-6. PubMed ID: 15581975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of integrin beta1 is a poor prognostic factor in small-cell lung cancer.
    Oshita F; Kameda Y; Ikehara M; Tanaka G; Yamada K; Nomura I; Noda K; Shotsu A; Fujita A; Arai H; Ito H; Nakayama H; Mitsuda A
    Anticancer Res; 2002; 22(2B):1065-70. PubMed ID: 12168902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role.
    Miyata Y; Iwata T; Maruta S; Kanda S; Nishikido M; Koga S; Kanetake H
    Eur Urol; 2007 Sep; 52(3):791-7. PubMed ID: 17207914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 expression as a predictor of chemosensitivities and survival in small cell lung cancer.
    Takayama K; Ogata K; Nakanishi Y; Yatsunami J; Kawasaki M; Hara N
    Cancer J Sci Am; 1996; 2(4):212-6. PubMed ID: 9166534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival in small cell lung cancer is independent of tumor expression of VEGF and COX-2.
    Dowell JE; Amirkhan RH; Lai WS; Frawley WH; Minna JD
    Anticancer Res; 2004; 24(4):2367-73. PubMed ID: 15330186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.